Lv3
370 积分 2023-11-24 加入
Bitter peptides and bitter taste receptors
1天前
已完结
The Discovery and Development of Liraglutide and Semaglutide
2天前
已完结
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
2天前
已完结
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
2天前
已完结
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
2天前
已完结
Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes
2天前
已完结
New developments in the prospects for GLP‐1 therapy
2天前
已完结
OVERVIEW OF GLP-1 AND ITS PHYSIOLOGY
2天前
已完结
Glucagon-like peptide 1 (GLP-1)
2天前
已完结
皖公网安备34019202002308
